pomalidomide

The medicinal product is used in adults for the treatment of multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

The medicinal product is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

The medicine is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

The medicine is used in adults with multiple myeloma (a type of white blood cell cancer). It is used in combination with other medicines, such as bortezomib and dexamethasone, or solely with dexamethasone, depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

The medicine is intended for adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults to treat multiple myeloma. It may be taken in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.

The medicine is intended for the treatment of adults with multiple myeloma (a type of white blood cell cancer). It is used in combination with other medicines, such as bortezomib and dexamethasone, or alone with dexamethasone, depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.

This medicine is used in adults with multiple myeloma (a type of malignant tumor that affects blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to the tumor.

Form: capsules, hard

ATC: L04AX06

Manufacturer: AS Grindeks

The medicine is used in adults with multiple myeloma (a type of malignant tumor that affects blood cells). It is used in combination with other medicines, such as bortezomib and dexamethasone, or solely with dexamethasone, depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: AS Grindeks

The medicinal product is used in adults for the treatment of multiple myeloma (a type of malignant neoplasm). It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.

Form: capsules, hard

ATC: L04AX06

Manufacturer: AS Grindeks

The medicine is used in adults for the treatment of multiple myeloma (a type of malignant tumor). It may be taken alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.

Form: capsules, hard

ATC: L04AX06

Manufacturer: AS Grindeks

The medicine is used in adults with multiple myeloma (a type of malignant cancer of the white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to them.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Pharmadox Healthcare Limited

The medicine is used in adults with multiple myeloma. It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to tumor cells.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Pharmadox Healthcare Limited

It is used in adults with multiple myeloma (a type of malignant cancer of the white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict the blood supply to them.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Pharmadox Healthcare Limited

The medicine is used in adults with multiple myeloma (a type of malignant tumor that attacks white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to them.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Pharmadox Healthcare Limited

This medicine is intended for the treatment of adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used in adults to treat multiple myeloma. It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used in adults to treat multiple myeloma. It may be administered in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicinal product is used in adults for the treatment of multiple myeloma. It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults for the treatment of multiple myeloma (a type of malignant cancer that attacks white blood cells). It is used in combination with other medicines, such as bortezomib or dexamethasone.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited Pharmadox Healthcare Limited Qualimetrix S.A.

The medicine is used in adults with multiple myeloma (a type of malignant tumor that affects white blood cells).

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited Pharmadox Healthcare Limited Qualimetrix S.A.

The medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults with multiple myeloma, a type of malignant tumor that affects white blood cells.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

This medicine is used in adults to treat multiple myeloma (a type of malignant cancer that affects white blood cells). It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

This medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines (bortezomib and dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited

This medicine is used in adults to treat multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited

The medicine is used in adults for the treatment of multiple myeloma (a type of malignant tumor that attacks white blood cells). It may be used alone with dexamethasone or in combination with other medicines, such as bortezomib.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited

This medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be used in combination with other medicines, such as bortezomib and dexamethasone, or with dexamethasone alone, depending on the patient's treatment history.

Form: capsules, hard

ATC: L04AX06

Manufacturer: Adalvo Limited